Alfasigma has acquired the marketing rights for Jyseleca, a JAK1 inhibitor drug used for rheumatoid arthritis and ulcerative colitis, following European Medicines Agency approval. This acquisition...
The Detmold district approved North Rhine-Westphalia’s first cannabis cultivation association, "Joints Venture," which began cultivation immediately. With 500 members, the association expects its first harvest by...
CrowdFundMe achieved positive EBITDA of €57,000 in the first half of 2024, compared to a loss of €77,000 in 2023, driven by its real estate lending...
Despite challenging market conditions, Moneyfarm has experienced strong growth, with assets increasing by 51% and clients by 23%, reaching 5 billion euros and over 130,000 clients....
Ripple is awaiting the SEC's decision on whether to appeal the XRP court ruling by October 7. Meanwhile, Ripple has secured regulatory approval in Dubai to...
The Fed’s emergency rate cuts aim to reduce government debt service costs but risk pushing long-term interest rates higher, worsening consumer debt burdens. Despite past rate...
Mangopay’s modular e-wallet and FX solution will help Paybyrd automate operations, streamline fund reconciliation, and offer a local experience by converting funds within the wallet. This...
Funds TOgether's third edition raised over €160,000, exceeding targets with 325% average overfunding. Five UniTo research projects were selected for crowdfunding, each with a €10,000 goal....
Botswana's economic growth slowed to 1% in the first nine months of 2024 due to a decline in diamond production, offset by construction projects. Diamond output...
Cannabis use remains at historic highs in 2023. Among 19-30 year-olds, 42% of adults reported using the substance in the past 12 months. Among 35-50 year-olds,...